ArticleScientific reports2026
A scanning electron microscopy-based approach to explore subpodocyte space remodeling in diabetic kidneys of mice and humans.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ultrastructural analysis of the subpodocyte space (SPS) is essential to understanding podocyte injury in diabetic nephropathy, where SPS expansion represents an early marker of glomerular dysfunction. While traditionally assessed by transmission electron microscopy (TEM), we previously established a scanning electron microscopy (SEM) protocol enabling high-resolution SPS visualization in perfused kidney tissue. However, perfusion-based fixation, though effective in animal models, is not feasible in patients during the biopsy retrieval. To overcome these limitations, we developed a rapid SEM protocol based on secondary electron detection, specifically optimized for non-perfused samples. Using a paired design in healthy and diabetic (BTBR ob/ob) mice, we compared perfused and contralateral non-perfused kidneys, showing that SPS morphology and quantification remained accurate even in the absence of perfusion. The protocol was successfully applied to human kidney biopsies from controls and diabetic patients, allowing reliable SPS assessment and ultrastructural analysis across entire glomerular cross-sections. This optimized SEM protocol provides a reliable and versatile approach for SPS analysis in both non-perfused preclinical models and human kidney biopsies, thus broadening its applicability to clinically relevant settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.